Implementing Genomic Medicine into Practice
April 27-29, 2017, Athens, Greece
The 3rd Global Genomic Medicine Collaborative Conference will be organized in Athens, Greece, April 27-29, 2017.
The meeting will be organized by the Global Genomic Medicine Collaborative and the Golden Helix Foundation, as the local host. The 3rd Global Genomic Medicine Collaborative Conference is the first to be organized in Europe, following the successful events in the United States in 2014 and Singapore in 2015 and will focus on the implementation of Genomic Medicine into clinical practice.
Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.
The 3rd Global Genomic Medicine Collaborative Conference organizing Committee
Organized by:
Local Organizer:
Endorsed by:
WelcomeAbout G2MCVenueSpeakersScientific ProgramSponsorsDownloadsGalleryImplementing Genomic Medicine into Practice
April 27-29, 2017, Athens, Greece
The 3rd Global Genomic Medicine Collaborative Conference will be organized in Athens, Greece, April 27-29, 2017.
The meeting will be organized by the Global Genomic Medicine Collaborative and the Golden Helix Foundation, as the local host. The 3rd Global Genomic Medicine Collaborative Conference is the first to be organized in Europe, following the successful events in the United States in 2014 and Singapore in 2015 and will focus on the implementation of Genomic Medicine into clinical practice.
Leaders in Genomic Medicine across the globe will be attending this highly interactive meeting to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care. Representatives from the developed and the developing world will share challenges and strategies to overcome them. In addition we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to impact health care delivery.
The 3rd Global Genomic Medicine Collaborative Conference organizing Committee
Organized by:
Local Organizer:
Endorsed by:
The Global Genomic Medicine Collaborative
Overview
The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care. Arising from the 2014 Global Leaders in Genomic Medicine Summit, the purpose of G2MC is to identify opportunities and foster global collaborations for enabling the demonstration of value and the effective use of genomics in medicine. Engaging multiple stakeholders across the globe, the G2MC group, under the auspices of the Roundtable on Genomics and Precision Health, seeks to improve global health by catalyzing the implementation of genomic tools and knowledge into health care delivery globally. To accomplish these goals, seven working groups were created, including communications, education, evidence, IT/bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.
Specifically, it is intended to:
- Serve as nexus, clearinghouse, and knowledge base for genomic medicine activities globally;
- Develop opportunities for global genomic medicine demonstration projects (implementation and outcomes research) and;
- Capture and disseminate best practices for genomic medicine (in bioinformatics, education, evidence, pharmacogenomics, policy) across the global genomic medicine community.
Current Activities
The purpose and goals of the Global Genomic Medicine Collaborative (G2MC):
- Develop projects with global participation
- Opportunities to disseminate learnings for genomic medicine implementation
- Educational platforms to support genomic medicine projects
- Community engagement and access to global genomic medicine expertise
- Creation of a registry or catalog of genomic medicine projects and programs across the globe to stimulate collaboration and efficiency in translation
- Be a global policy forum for genomic medicine
- Mapping the global genomic medicine landscape particularly as it relates to policy and implementation
- Global eradication of preventable Stevens Johnson Syndrome/Toxic Epidermal Necrolysis
Previous Conferences
2nd G2MC Conference; November 6-7, 2015, Singapore – Implementing Genomic Medicine into Practice
The meeting objectives were to:
- Highlight nations or organizations around the world that are implementing genomic medicine into practice
- Foster/facilitate collaborations to enable the implementation of genomic medicine
- Highlight best practices and lessons learned to enable others to effectively implement genomic medicine approaches
- Identify and develop solutions for overcoming obstacles to genomic medicine implementation
- Identify and discuss regulations and policies that impact the implementation of genomic medicine
- Create a global tool box for implementation of genomic medicine into practice
1st G2MC Conference; January 8-9, 2014, Washington DC, USA – Global Leaders in Genomic Medicine
The goals of the meeting were to:
- Identify areas of active translational and implementation research, potential common strategies, and opportunities for collaborative efforts.
- Identify common barriers to implementation of genomics in healthcare and a policy agenda relevant to advances in the field.
- Identify nations with unique capabilities (such as national healthcare systems) that may allow rapid implementation and measures of key outcomes.
- Discuss opportunities (such as national healthcare system) that may allow rapid implementation and measures of key outcomes.
Venue of the 3rd Global Genomic Medicine Collaborative Conference
The 3rd Global Genomic Medicine Collaborative Conference will be held in the DIVANI Apollon Palace and Thalasso*****.
Divani Apollon Palace and Thalasso is a member of the Leading hotels of the world. This is a luxury beach resort in Athens situated in the exclusive area of Vouliagmeni, just 18km from the city centre. Guests enjoy, the pleasure of a private beach and an award winning Spa, the only one offering Thalassotherapy in the whole Attica region and one of the best Thalassotherapy centers in the Mediterranean.
Divani Apollon Palace and Spa is an excellent hotel for both leisure and business and offers quiet luxury at the prestigious Athenian Riviera.
Conference Organizing Committee
Geoff Ginsburg (Durham, NC, USA)
Robyn Ward (Melbourne, Australia; Co-chair)
George P. Patrinos (Patras, Greece; Local Chair)
Fahd Al-Mulla (Safat, Kuwait)
Vajira Dissanayake (Colombo, Sri Lanka)
Peter Goodhand (Montreal, Canada)
Theodora Katsila (Patras, Greece)
Bruce Korf (Birmingham, AL, USA)
Teri Manolio (Baltimore, MD, USA)
Alan Shuldiner (Tarrytown, NY, USA)
Keynote Speakers
Victor Dzau (Washington DC, USA)
Stylianos Antonarakis (Geneva, Switzerland)
Speakers and Moderators
Takeya Adachi (Tokyo, Japan)
Spiros Agathos (Urcuqui, Ecuador)
Fahd Al-Mulla (Safat, Kuwait)
François Bernier (Toronto, Canada)
Jeffrey Braithwaite (Melbourne, Australia)
Mark Caulfield (London, UK)
Wasun Chantratita (Bangkok, Thailand)
Collet Dandara (Cape Town, South Africa)
Vajira Dissanayake (Colombo, Sri Lanka)
Geoff Ginsburg (Durham, NC, USA)
Peter Goodhand (Montreal, Canada)
Sue Hill (London, UK)
Magnus Ingelman-Sundberg (Stockholm, Sweden)
Federico Innocenti (Chapel Hill, NC, USA)
Said Ismail (Doha, Qatar)
Summer Kahlon (Satellite beach, FL, USA)
Bruce Korf (Birmingham, AL, USA)
Dhavendra Kumar (Cardiff, Wales)
Guilherme Suarez-Kurtz (Rio de Janeiro, Brazil)
Alberto Lecaros (Santiago, Chile)
Yixue Li (Shanghai, P.R. China)
Catalina Lopez-Correa (Vancouver, Canada)
Laura Lyman Rodriguez (Baltimore, MD, USA)
Teri Manolio (Baltimore, MA, USA)
George P. Patrinos (Patras, Greece)
Markus Paulmichl (Vienna, Austria)
Sir Munir Pirmohamed (Liverpool, UK)
Martin Reese (Oakland, CA, USA)
Gad Rennert (Haifa, Israel)
Gabriella Repetto (Santiago, Chile)
Ron H. van Schaik (Rotterdam, the Netherlands)
Alan Shuldiner (Tarrytown, NY, USA)
Andrew Sinclair (Melbourne, Australia)
Jesse Swen (Leiden, the Netherlands)
Patrick Tan (Durham, NC, USA)
Domenica Taruscio (Rome, Italy)
Aspasia Tsezou (Larissa, Greece)
Joris Veltman (Newcastle, UK)
Robyn Ward (Melbourne, Australia)
Grant Wood (Montreal, Canada)
Sarah Wordsworth (Oxford, UK)
Marc S. Williams (Philadelphia, PA, USA)
Scientific Program
Day 1 – Thursday April 27, 2017
10:00 – 13:00 Registration
13:00 – 13:10 Welcoming Remarks
Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA
Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia
George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras, Greece
13:10 – 13:25 Welcome from Greek Genetics Society
Aspasia Tsezou, President, Hellenic Association of Medical Geneticists, Greece
13:25 – 13:55 Keynote Lecture #1
Victor Dzau, President, National Academy of Medicine, USA
SESSION I: LARGE_SCALE NATIONAL SEQUENCING PROGRAMS: IMPACT ON CLINICAL MEDICINE
Moderator: Alan Shuldiner, Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA
14:00 The Qatar Genome Program; An Overview
Said Ismail, Programme Manager, Genome Qatar, Qatar
14:15 United States: PMI and Million Veterans Program
Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute, USA
14:30 China’s Precision Medicine Initiative
Yixue Li, Professor, Shanghai Institutes for Biological Sciences, China
14:45 UK: 100,000 Genomes Project
Mark Caulfield, Co-Director, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, UK
15:00 Australian Genomics Health Alliance: implementing genomics into health care
Andrew Sinclair, Deputy Director, Murdoch Children’s Research Institute, Australia
15:15 The Clalit Israeli 100K Personalized Medicine RCT
Gad Rennert, Director, Clalit National Israeli Cancer Control Center, Israel
15:30 Panel discussion
Opening remarks: Chen-Yang Shen, Chief Executive, Taiwan Biobank, Taiwan
16:00 – 16:15 COFFEE BREAK
SESSION II: PROGRESS IN DIAGNOSING RARE DISEASES _ INTERNATIONAL OPPORTUNITIES
Moderator: Teri Manolio, Director, Division of Genomic Medicine, National Human Genome Research Institute (USA)
16:15 Undiagnosed severe intellectual disability
Joris Veltman, Director, Institute of Genetic Medicine, Newcastle University, UK
16:30 Undiagnosed Diseases Network International
Domenica Taruscio, Director, Istituto Superiore di Sanita (ISS), Italy
16:45 Next generation sequencing for rare pharmacogenomics variants
Magnus Ingelman-Sundberg, Professor, Karolinska Institutet, Sweden
17:00 Japan’s Initiative on Rare and Undiagnosed Diseases (IRUD): Towards integrative diagnosis network for universal healthcare system
Takeya Adachi, AMED Program Officer, Japan Agency for Medical Research & Development (AMED), Japan
17:15 Enhanced Care for Rare Diseases Canada
François Bernier, Associate Professor, Department of Medical Genetics, Alberta Children’s Hospital, Canada
17:30 The University of Alabama at Birmingham Undiagnosed Diseases Program
Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham, USA
17:45 – 18:15 Panel discussion
18:30 WELCOME COCKTAIL RECEPTION
Day 2 – Friday April 28, 2017
08:15 Opening Remarks
Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA
Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia
08:20 Keynote Introduction
George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology,University of Patras, Greece
08:25 Keynote Lecture #2
Stylianos Antonarakis, Professor and Chairman of Genetic Medicine, University of Geneva Medical School, Switzerland
SESSION III: NATIONAL GENOMIC MEDICINE PROGRAMS: IMPLEMENTATION
Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University
09:00 Kuwait Genome Program
Fahd Al-Mulla, Director of Genomic Medicine Center and Professor of Molecular Pathology, Kuwait University, Dasman Diabetes Institute, Kuwait
09:15 Implementing Genomic Medicine in Sri Lanka [pre-taped video presentation]
Vajira Dissanayake, Chair & Professor of Anatomy and Medical Geneticist, University of Colombo, Sri Lanka
09:30 South America
Gabriella Repetto, Director, Center for Genetics and Genomics, Universidad del Desarrollo, Chile
09:45 The economics of next-generation sequencing
Sarah Wordsworth, Associate Professor, Oxford University, UK
10:00 National Scale Precision Medicine in Singapore
Patrick Tan, Professor, Cancer and Stem Cell Biology Program, Duke NUS Medical School, Singapore
10:15 IGNITE network
Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA
10:30 Panel discussion
SESSION IV: DATA SCIENCE (WITH GA4GH)
Moderators: Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Grant Wood, Senior IT Strategist, Clinical Genetics Institute at Intermountain Healthcare
11:00 Accurate and Rapid WGS Interpretation with Fabric Genomics
Martin Reese, Co-founder, President, and Chief Scienti_c O_cer, Fabric Genomics, USA
11:15 Clinical contextualization of lab results
Marc S. Williams, Director, Genomic Medicine Institute, Geisinger Health System, USA
11:30 Oracle Family Health History Project
Summer Kahlon, Director, Care Innovation, Oracle Health Sciences, USA
Grant Wood, Senior Strategist, Intermountain Healthcare Clinical Genetics Institute, USA
11:45 Establishing a Longitudinal Genetic/Genomic-Based EHR for Clinical Care
Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Canada
12:00 Q&A with session speakers and audience
Discussion topic: What are the issues in your country to accomplish the goals of a longitudinal genomic patient record?
12:30 LUNCH BREAK
SESSION V: POLICY AND WORKFORCE GENERATION
Moderator: Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia, Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham
13:30 The Implementation of Genomic Medicine in the NHS in England
Sue Hill, Chief Scientific Officer, NHS England, UK
13:45 Genomic Test Evaluation Frameworks
Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research, The University of Queensland, Australia
14:00 Implementing Genomics in the Health Care System in Canada
Catalina Lopez-Correa, Chief Scientific Officer and Vice President, Sectors, Genome British Columbia, Vancouver, Canada
14:15 More than regulatory challenges for genomic medicine in Latin America
Alberto Lecaros, Observatory for BioEthics and Law, Universidad del Desarrollo, Santiago, Chile
14:30 Establishing a Latin American Translational Genomics Institute
Spiros Agathos, Dean, School of Life Sciences, Yachay Tech University, Ecuador
14:45 Implementation Science Meets Genomic Medicine: Ideas, Issues & Innovations
Jeffrey Braithwaite, Professor of Health Systems Research, Founding Director, Australian Institute of Health Innovation, Macquarie University, Australia
15:00 Fostering Genomic Literacy for Today and Tomorrow
Laura Lyman Rodriguez, Director, Division of Policy, Communications, and Education, National Human Genome Research Institute (NHGRI), USA
15:15 Genomic education for empowering the Multi-Disciplinary Healthcare
Dhavendra Kumar, Visiting Professor, Genomic Policy Unit, Faculty of Life Sciences & Education, University of South Wales, UK, Consultant in Clinical Genetics, University Hospital of Wales, UK
15:30 Panel discussion
16:00 BREAK
16:15 – 17:30 Breakout Sessions
A) National Programs: Implementation [Location: Platon]
Chair: Alan Shuldiner, Vice President, Regeneron Genetics Center, Regeneron Pharmaceuticals, Inc., USA
B) Pharmacogenomics [Location: Platon]
Chair: George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical BiotechnologyUniversity of Patras, Greece
C) Policy [Location: Athina A]
Chair: Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research The University of Queensland, Australia
D) Education and Workforce [Location: Athina B]
Chair: Bruce Korf, Wayne H. and Sara Crews Finley Chair in Medical Genetics, Professor and Chair, Department of Genetics, University of Alabama, Birmingham, USA
E) IT/Bioinformatics & Family Health History Project [Location: Poseidon A]
Chairs: Peter Goodhand, Executive Director, Global Alliance for Genomics and Health, Canada, Grant Wood, Senior Strategist, Intermountain Healthcare Clinical Genetics Institute, USA
F) Evidence [Location: Poseidon B]
Chairs: Marc Abramowicz, Professor and Head, Dept. of Medical Genetics, Université. Libre de Bruxelles, Brussels, Fahd Al-Mulla, Director of Genomic Medicine Center and Professor of Molecular Pathology,Kuwait University, Dasman Diabetes Institute, Kuwait
18:00 Depart for Dinner
Tour of Acropolis Museum
20:00 DINNER
Location: Acropolis Museum
Day 3 – Saturday April 29, 2017
07:00 – 08:00 G2MC Steering Committee Meeting (by invitation only)
08:00 Opening Remarks
Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University, USA
Robyn Ward, Deputy Vice-Chancellor of Research, and Vice President of Research, The University of Queensland, Australia
SESSION VI: PHARMACOGENOMICS IN THE CLINIC: INTERNATIONAL PROGRESS
Moderator: George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology, University of Patras, Greece
08:10 Implementation of Pharmacogenomics in the Clinic
Sir Munir Pirmohamed, Professor, University of Liverpool, Wolfson Institute of Personalized Medicine, UK
08:20 Genomic Medicine; Safety first
Federico Innocenti, Associate Director; Associate Professor; Center of Pgarmacogenomics and Individualized Therapy; Associate Professor; University of North Carolina, Chapel Hill, USA
08:30 The Ubiquitous Pharmacogenomics (UPGx) project
Jesse Swen, Associate Professor, Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Netherlands
08:40 PGx Activities in Latin America
Guilherme Suarez-Kurtz, Professor, Instituto Nacional de Câncer, Brazil
08:50 Public Health Pharmacogenomics
George P. Patrinos, Associate Professor of Pharmacogenomics and Pharmaceutical Biotechnology,University of Patras, Greece
09:00 Implementation of PGx in the Austrian Healthcare System
Markus Paulmichl, Medical Advisor, Centre for Health and Bioresources, Austrian Institute of Technology, Austria
09:10 European Society of Pharmacogenomics
Ron van Schaik, Full Professor, Pharmacogenetics Erasmus Medical Center, Netherlands
09:20 Pharmacogenomics research and implementation in Africa
Collet Dandara, Professor, Department of Clinical & Laboratory Sciences, University of Cape Town, South Africa
09:30 The SEAPharm Consortium
Wasun Chantratita, Associate Professor, Department of Pathology, Ramathibidi Hospital, Thailand
09:40 Panel discussion
10:15 – 10:30 BREAK
10:30 – 12:00 Breakout Reports and Discussion
Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University
12:00 – 13:00 WORKING LUNCH [G2MC Steering Committee meeting (continued; by invitation only)]
SESSION VII: IMPLEMENTATION OF GENOMIC MEDICINE BY THE PRIVATE SECTOR
Moderator: Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine, Biomedical Engineering and Pathology, Duke University
13:15 De novo assembly of Asian diploid genome (AK1)
Changhoon Kim, Director, Bioinformatics Institute, Macrogen, South Korea
13:30 The Science May be the Easy Part: Challenges and Solutions in Implementing a Molecular Diagnostic Test
James Wingrove, Vice President Technical Operations, Head of Research, CardioDx, USA
13:45 From human genetic insights to drug discovery impact
Nadeem Sarwar, President, Eisai AiM Institute, USA
14:00 Genomic Medicine Enabled Through Partnership
David Bentley, Vice President and Chief Scientist, Illumina, UK
14:15 Closing remarks
Geoff Ginsburg, Director, Duke Center for Applied Genomics & Precision Medicine, Professor of Medicine,Biomedical Engineering and Pathology, Duke University, USA
Robyn Ward, Deputy Vice-Chancellor (Research) and Vice President (Research), The University of Queensland, Australia
14:30 MEETING ADJOURNS
Sponsors
We are grateful to the following corporate entities for generously supporting this event.
Click here to download the Scientific Program.
Click here to download the Abstract book of the Conference.
